Zobrazeno 1 - 8
of 8
pro vyhledávání: '"LMP1, Latent membrane protein 1"'
Publikováno v:
Fundamental Research
The sudden outbreak of COVID-19 has once again shrouded people in the enormous threat of RNA virus. Extracellular vesicles (EVs), eukaryotic cells-derived small bi-layer vesicles mainly consisting of exosomes and microvesicles, share many properties
TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells
Publikováno v:
The Journal of Biological Chemistry
TRAF3 has diverse signaling functions, which vary by cell type. Uniquely in B lymphocytes, TRAF3 inhibits homeostatic survival. Highlighting the role of TRAF3 as a tumor suppressor, loss-of-function TRAF3 mutations are associated with human B-cell ma
Autor:
Kerstin Thriene, Christian Münz, Urs Ziegler, Heike Nowag, Joern Dengjel, Bruno Guhl, Susana Romao
Publikováno v:
EBioMedicine, Vol 1, Iss 2, Pp 116-125 (2014)
EBioMedicine
EBioMedicine
Epstein Barr virus (EBV) persists as a latent herpes virus infection in the majority of the adult human population. The virus can reactivate from this latent infection into lytic replication for virus particle production. Here, we report that autopha
Publikováno v:
Advanced Drug Delivery Reviews
Advanced Drug Delivery Reviews, 65(3), 348-356. Elsevier
Koppers-Lalic, D, Hogenboom, M M, Middeldorp, J M & Pegtel, D M 2013, ' Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine ', Advanced Drug Delivery Reviews, vol. 65, no. 3, pp. 348-356 . https://doi.org/10.1016/j.addr.2012.07.006
Advanced Drug Delivery Reviews, 65(3), 348-356. Elsevier
Koppers-Lalic, D, Hogenboom, M M, Middeldorp, J M & Pegtel, D M 2013, ' Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine ', Advanced Drug Delivery Reviews, vol. 65, no. 3, pp. 348-356 . https://doi.org/10.1016/j.addr.2012.07.006
A major goal in biomedical research is to clinically reverse the cause of disease rather than treating the symptoms. Gene therapy has the potential to meet this goal and the discovery of RNA interference (RNAi) has lead to a new class of highly selec
Publikováno v:
Вопросы вирусологии.
Широко распространенный среди населения планеты вирус Эпштейна-Барр (ВЭБ) является этиологическим агентом для ряда злокачественных но
Publikováno v:
Вестник РОНЦ им. Н. Н. Блохина РАМН.
Целью работы стало изучение полиморфизма (дивергентности) онкогена LMP1 вируса ЭпштейнаБарр у больных раком носоглотки и лиц контрольных
Autor:
Kolenda T; Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland.; Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warszawa, Poland., Guglas K; Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warszawa, Poland., Kopczyńska M; Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland.; Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland., Sobocińska J; Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland., Teresiak A; Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland., Bliźniak R; Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland., Lamperska K; Laboratory of Cancer Genetics, Greater Poland Cancer Centre, Poznan, Poland.
Publikováno v:
Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [Rep Pract Oncol Radiother] 2020 Sep-Oct; Vol. 25 (5), pp. 808-819. Date of Electronic Publication: 2020 Aug 12.
Autor:
Nowag H; Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, 8057 Zürich, Switzerland., Guhl B; Center for Microscopy and Image Analysis, University of Zürich, 8057 Zürich, Switzerland., Thriene K; Department of Dermatology, Medical Center, University of Freiburg, Hauptstr. 7, 79104 Freiburg, Germany ; Freiburg Institute for Advanced Studies, University of Freiburg, Albertstr. 19, 79104 Freiburg, Germany ; BIOSS Centre for Biological Signalling Studies, University of Freiburg, Schänzlestr. 18, 79104 Freiburg, Germany ; ZBSA Center for Biological Systems Analysis, University of Freiburg, Habsburgerstr. 49, 79104 Freiburg, Germany., Romao S; Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, 8057 Zürich, Switzerland., Ziegler U; Center for Microscopy and Image Analysis, University of Zürich, 8057 Zürich, Switzerland., Dengjel J; Department of Dermatology, Medical Center, University of Freiburg, Hauptstr. 7, 79104 Freiburg, Germany ; Freiburg Institute for Advanced Studies, University of Freiburg, Albertstr. 19, 79104 Freiburg, Germany ; BIOSS Centre for Biological Signalling Studies, University of Freiburg, Schänzlestr. 18, 79104 Freiburg, Germany ; ZBSA Center for Biological Systems Analysis, University of Freiburg, Habsburgerstr. 49, 79104 Freiburg, Germany., Münz C; Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, 8057 Zürich, Switzerland.
Publikováno v:
EBioMedicine [EBioMedicine] 2014 Nov 08; Vol. 1 (2-3), pp. 116-25. Date of Electronic Publication: 2014 Nov 08 (Print Publication: 2014).